Herein, you’ll find latest pharma news in India – January 21st, 2021 Edition. Also, you’ll find latest news on sun pharma from reliable and authentic sources.
Latest Pharma News in India
- Algernon Pharma receives DSMB nod to conduct phase 3 study of Ifenprodil to treat Covid-19
- NIH researchers discover Jekyll and Hyde immune cells in brain which may help with brain repair
- Ayurvedic remedy outperforms pharmaceuticals in Covid-19 comparative clinical trial
- Vice President recommends Union health minister to consider setting up vaccine testing and certification lab in Hyderabad
- US FDA accepts Precision BioSciences’ IND application for PBCAR19B to treat r/r non-Hodgkin lymphoma
- Vedanta’s first Covid vaccination held at its Jharsuguda aluminium plant in Odisha
- Dr Harsh Vardhan unveils IEC campaign to address vaccine hesitancy and misinformation
- US FDA grants breakthrough device designation to Occlutech’s Atrial Flow Regulator for heart failure
- Genesis Medtech collaborates with Penumbra to expand neurovascular market in China
- Secarna’s partner Lipigon Pharma selects drug candidate, Lipisense to treat elevated levels of plasma lipid triglycerides
- Hamdard Labs launches twelve new Unani medicines
- India is known as the hub for Covid-19 vaccine production: Dr Randeep Guleria
- European Commission approves extension of indication for Sobi’s Doptelet to treat ITP
- Akron Biotech inks agreement with Octapharma to produce virally inactivated Human AB Serum derived from Octaplas for cell therapy market
- Aptorum Group gets Health Canada nod to begin phase 1 trial of small molecule drug, ALS-4 for infections caused by Staphylococcus aureus including MRSA
- Healthcare witnesses record spike in hiring across sector: Talent Trends 2021 Report
- FIP and WHO develop new curriculum guide to improve action against substandard and fake medicines
- Syngene in Q3 sees revenue from operations up by 13% to Rs. 585 crore, PAT up 11% to Rs. 102 crore
- AstraZeneca, Daiichi Sankyo’s Enhertu gets European approval to treat HER2-positive metastatic breast cancer
- Lilly, Merus ink research collaboration to discover novel T-cell re-directing bispecific antibodies
- Thermo Fisher Scientific to acquire molecular diagnostic company, Mesa Biotech for US$ 450 million
Pharma Sector News Today
Eli Lilly says its monoclonal antibody prevented Covid-19 infections in clinical trial
Pieris finally vaults FDA hold on next-gen solid tumor hunter, clearing the path for mid-stage trial
Russia asks for “non-political” treatment of Sputnik V shot, then rules out US filing
Haemonetics inks $510M Cardiva takeover to expand hospital business
CMS expands transcatheter mitral coverage, boosting Abbott’s MitraClip device
With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
2020 drug approvals rise despite Covid-19
BIO Shakes Things Up to Align Leadership with New Vision
After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO
This Medical Device Maker Will Be Well Positioned Post COVID
California says batch of Moderna vaccine is safe, despite reports of illnesses
Latest News on Sun Pharma
Corporate Action-Board to consider Dividend
Sun Pharmaceutical Industries Statement Of Investor Complaints For The Quarter Ended December 2020
Sun Pharma Q3 PAT seen up 44.4% YoY to Rs 1,319 cr: ICICI Direct
Buy Sun Pharmaceutical Industries: target of Rs 660 : Sharekhan
Sun Pharma to consider declaration of interim dividend for FY 2020-21
L&T Tech, Bajaj Finance, Axis Bank, Sun Pharma, UltraTech Cement (Stocks in news)
Receive latest and reliable pharma news in India. We at OMENSOL endeavor to provide you with authentic pharma sector news daily.
Tags:
pharma news in india, sun pharma latest news, pharma sector news today, latest news on sun pharma
